Stem cell-based test predicts leukemia patients’ response to therapy
Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment. The findings could potentially transform patient care in AML by giving clinicians a risk scoring tool that within a day or […]
